Exostosin 2 (EXT2) (C-Term) Peptide
Quick Overview for Exostosin 2 (EXT2) (C-Term) Peptide (ABIN8100093)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- EXT2 Peptide - C-terminal region
-
Sequence
- LTYDRVESLF RVITEVSKVP SLSKLLVVWN NQNKNPPEDS LWPKIRVPLK
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-EXT2 Antibody (ARP73848_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- EXT2 (Exostosin 2 (EXT2))
-
Background
-
Background Information: This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
Alternative Symbols: EXT2,
-
Molecular Weight
- 78kDa
-
Gene ID
- 2132
-
NCBI Accession
- NP_997005
-
UniProt
- Q93063
Target
-